Thursday, August 28, 2014
FAIRFIELD-SUISUN, CALIFORNIA
99 CENTS

Genentech Alzheimer’s drug misses goals in studies

By
From page A5 | July 17, 2014 |

An experimental drug from the biotech company Genentech failed to slow mental decline in mid-stage studies on more than 500 people with mild to moderate Alzheimer’s disease, but showed some promise in the least-impaired participants who received a higher dose.

Pneumonia and deaths were more common among those receiving the drug, but researchers downplayed that. Study leader Dr. Jeffrey Cummings of the Cleveland Clinic said none of the deaths seemed due to the drug and pneumonia occurred at a rate to be expected in older people.

“We’re very encouraged” by the hint of benefit for patients with milder dementia and will talk with regulators about next steps for the drug, crenezumab (cruh-NEZ-oo-mab), said a Genentech scientist, Dr. Carole Ho. The results fit with other evidence suggesting that treating earlier in the course of the disease is better, she said.

Results were revealed Wednesday at the Alzheimer’s Association International Conference in Copenhagen.

They are the latest mixed bag on treatments aimed at clearing away the sticky amyloid plaques clogging Alzheimer’s patients’ brains. About 35 million people worldwide have Alzheimer’s, the most common form of dementia. There is no cure and current treatments only temporarily ease symptoms.

Last year, an Eli Lilly & Co. medicine, solanezumab, that also sought to clear away amyloid missed main goals in two studies but combined results suggested it might help people with milder disease. It’s in further study now. Before that, bapineuzumab, a similar drug being developed by Pfizer Inc. and Johnson & Johnson, showed promise in mid-stage testing but flopped in larger, more definitive trials.

The Genentech drug has been closely watched because it targets amyloid more broadly than the other drugs do, and the California-based company has a long track record of success with many biological medicines against cancer.

Mid-stage studies aim to give some idea of safety and whether the drug is effective enough to advance to larger, more definitive studies aimed at winning market approval.

In one study, 431 patients ages 50 to 80 with mild to moderate Alzheimer’s were given crenezumab or dummy drug as shots every two weeks, or as a higher dose in infusions every four weeks for 17 months. No significant difference was seen among the groups on two widely used measures of thinking and functioning skills.

However, the 70 most mildly impaired participants who received the higher dose declined 35 percent less on the cognitive measure than the 33 mildly impaired people given dummy infusions. The difference was about 3.5 points on the roughly 70-point scale — “equivalent to six or nine months” of delay in decline, Cummings said.

This result isn’t definitive, though, and can only be considered a signal worth exploring in future research because it didn’t involve the whole group tested. And even in this mildly impaired group, the drug did not improve the second measure, ability to function in daily life.

In the second study, 73 people who showed amyloid plaques on brain imaging also were given crenezumab or dummy shots or infusions. The main outcome — levels of amyloid seen on brain imaging after treatment — will be presented at a medical conference in November. Results on cognitive function seem to mirror those in the larger study, Cummings said.

Five people given crenezumab died — one from sudden death, two from respiratory failure, one from pneumonia and one from worsening Alzheimer’s.

“We believe that the safety profile is acceptable,” because deaths do not seem related to the drug, Genentech’s Ho said. “It is not a show stopper.”

Genentech and its corporate parent, Switzerland-based Roche Holding AG, paid for the study and Cummings is a paid adviser to Genentech.

In a statement Wednesday, the Alzheimer’s Association noted that crenezumab was being tested in another study aimed at preventing the disease, and said the new results give hope it will be more successful in that setting.

___

Online:

National Institute on Aging: http://www.nia.nih.gov/Alzheimers

Patient, family info: http://www.alzheimers.gov/

Alzheimer’s Association: http://www.alz.org

 

The Associated Press

The Associated Press

LEAVE A COMMENT

Discussion | No comments

The Daily Republic does not necessarily condone the comments here, nor does it review every post. Read our full policy

.

Solano News

Locke an unparalleled universe in the Delta

By Susan Winlow | From Page: A1 | Gallery

 
Small-town heroism on display in Napa

By Angela Borchert | From Page: A2

 
Review set for Vacaville fitness center suit

By Ryan McCarthy | From Page: A3

 
Fairfield motorcyclist hurt in Beck Avenue crash

By Ian Thompson | From Page: A3

 
 
Logue misses meet with Libertarians in Fairfield

By Ryan McCarthy | From Page: A4

Chamber event looks at health care law

By Barry Eberling | From Page: B5 | Gallery

 
Fairfield police log: Aug. 26, 2014

By Susan Hiland | From Page: A5

Winterhawk Winery up for auction

By Barry Eberling | From Page: B5 | Gallery

 
Suisun City police log: Aug. 26, 2014

By Susan Hiland | From Page: A5

.

US / World

Boy hurt in California quake: ‘I should be dead’

By The Associated Press | From Page: A1 | Gallery

 
California Senate passes gun restraining order

By The Associated Press | From Page: A5

Lawmakers approve groundwater management bill

By The Associated Press | From Page: A5

 
California sets ride-sharing insurance standards

By The Associated Press | From Page: A5

Feds allow logging after huge California wildfire

By The Associated Press | From Page: A5

 
California beach town sees flooding from hurricane

By The Associated Press | From Page: A5

Q-and-A on Westerners who join the fight in Syria

By The Associated Press | From Page: A6

 
Sources: US considering new relief mission in Iraq

By The Associated Press | From Page: A6

Shooting by 9-year-old girl stirs debate over guns

By The Associated Press | From Page: A6

 
US to consider spousal abuse in immigration claims

By The Associated Press | From Page: A6

UK sex abuse report prompts outrage, reflection

By The Associated Press | From Page: A6

 
Dad acquitted in slaying of driver who killed sons

By The Associated Press | From Page: A6

Q&A: Few laws govern children at shooting range

By The Associated Press | From Page: A6

 
Mom pleads for release of captive US journalist

By The Associated Press | From Page: A6 | Gallery

Israeli premier, Hamas declare victory in Gaza war

By The Associated Press | From Page: A6 | Gallery

 
.

Opinion

Seizing the day with old friends

By Kelvin Wade | From Page: A11

 
Signs of possible healing in Ferguson

By Jay Ambrose | From Page: A11

 
Poor constituent service no longer acceptable

By Ruben Navarrette | From Page: A11

Editorial Cartoons: Aug. 28, 2014

By Kim Durbin | From Page: A11

 
Let’s improve entertainment control units

By Letter to the Editor | From Page: A11

.

Living

Community Calendar: Aug. 28, 2014

By Susan Hiland | From Page: A2

 
Today in History: Aug. 28, 2014

By The Associated Press | From Page: A2

My boss insists that we all eat lunch with her in cafeteria

By Kathy Mitchell and Marcy Sugar | From Page: A9

 
Horoscopes: Aug. 28, 2014

By Holiday Mathis | From Page: A9

.

Entertainment

TVGrid

By Daily Republic Syndicated Content | From Page: B5

 
Judge lets ‘X-Men’ director’s accuser drop lawsuit

By The Associated Press | From Page: A10

Rapper Young Jeezy pleads not guilty to gun charge

By The Associated Press | From Page: A10

 
‘Cops’ crew member killed in Omaha police shooting

By The Associated Press | From Page: A10

Chris Soules is ABC’s new ‘Bachelor’

By The Associated Press | From Page: A10

 
John Lennon’s killer sorry for being ‘an idiot’

By The Associated Press | From Page: A10

Reality star accused of rape, child molestation

By The Associated Press | From Page: A10

 
Source: BET suspends producer after Blue Ivy joke

By The Associated Press | From Page: A10

.

Sports

Fuld’s homer in 9th lifts A’s over Astros 5-4

By The Associated Press | From Page: B1

 
Posey hits game-ending 2-run homer for Giants

By The Associated Press | From Page: B1

 
Maria Sharapova comes through in 3 sets at US Open

By The Associated Press | From Page: B1 | Gallery

Raiders rookie QB Derek Carr to start vs. Seahawks

By The Associated Press | From Page: B1

 
Cal needs more from its running game

By The Associated Press | From Page: B2

Stanford’s Kevin Hogan a ‘stabilizing agent’ at QB

By The Associated Press | From Page: B2 | Gallery

 
Chicago’s Little League champs return as heroes

By The Associated Press | From Page: B2 | Gallery

NFL suspends Browns star WR Gordon for 2014 season

By The Associated Press | From Page: B2

 
Keenum, Savage to settle Texans’ backup QB duel vs. 49ers

By The Associated Press | From Page: B2

USC’s Shaw admits to lying about injuries, rescue

By The Associated Press | From Page: B2

 
IndyCar sets April 12 New Orleans date

By The Associated Press | From Page: B2

No. 23 UNC suspends 4 players for opener

By The Associated Press | From Page: B2

 
Clippers sign Doc Rivers to 5-year extension

By The Associated Press | From Page: B2

Raiders hope rebuild pays immediate dividends

By The Associated Press | From Page: B3

 
After trio of near misses, 49ers chase Super Bowl

By The Associated Press | From Page: B3

.

Business

US economy forecast to grow by 1.5 percent in 2014

By The Associated Press | From Page: B6

 
Malaysia Airlines set for shakeup after disasters

By The Associated Press | From Page: B7

IMF chief Lagarde under investigation in France

By The Associated Press | From Page: B7

 
SEC adopts rules on loan-backed securities

By The Associated Press | From Page: B7

Stocks drift higher; S&P 500 holds on to 2,000

By The Associated Press | From Page: B7

 
Reports: FBI probes JPMorgan hack

By The Associated Press | From Page: B7

Time Warner Cable says outages largely resolved

By The Associated Press | From Page: B7

 
Video games come of age as spectator sport

By The Associated Press | From Page: B7

.

Obituaries

Frank W. Moy Jr.

By Nancy Green | From Page: A4

 
Gary Allen Person

By Nancy Green | From Page: A4

Fernanda Dee Villarosa

By Nancy Green | From Page: A4

 
Herman P. Sorensen

By Nancy Green | From Page: A4

Lyle R.C. Cullum

By Susan Hiland | From Page: A4

 
.

Comics

Frank and Ernest

By Daily Republic Syndicated Content | From Page: A8

 
Wizard of Id

By Daily Republic Syndicated Content | From Page: A8

B.C.

By Daily Republic Syndicated Content | From Page: A8

 
Sally Forth

By Daily Republic Syndicated Content | From Page: A8

Garfield

By Daily Republic Syndicated Content | From Page: A8

 
Dilbert

By Daily Republic Syndicated Content | From Page: A8

Get Fuzzy

By Daily Republic Syndicated Content | From Page: A8

 
Baldo

By Daily Republic Syndicated Content | From Page: A8

For Better or Worse

By Daily Republic Syndicated Content | From Page: A8

 
Beetle Bailey

By Daily Republic Syndicated Content | From Page: A8

Blondie

By Daily Republic Syndicated Content | From Page: A8

 
Baby Blues

By Daily Republic Syndicated Content | From Page: A8

Pickles

By Daily Republic Syndicated Content | From Page: A8

 
Zits

By Daily Republic Syndicated Content | From Page: A8

Peanuts

By Daily Republic Syndicated Content | From Page: A8

 
Rose is Rose

By Daily Republic Syndicated Content | From Page: A8

Cryptoquote

By Daily Republic Syndicated Content | From Page: A9

 
Crossword

By Daily Republic Syndicated Content | From Page: A9

Word Sleuth

By Daily Republic Syndicated Content | From Page: A9

 
Sudoku

By Daily Republic Syndicated Content | From Page: A9

Bridge

By Daily Republic Syndicated Content | From Page: A9